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Abstract
Background: Oxysterols are oxidized forms of cholesterol. They have been shown to be implicated in cholesterol turnover,
inflammation and in neurodegenerative diseases such as Alzheimer’s disease and multiple sclerosis. Glial cells are targets of
oxysterols: they inhibit astrocyte proliferation after brain injury, and we have previously shown that 25-hydroxycholesterol
(25OH) provokes oligodendrocyte apoptosis and stimulates the expression of sPLA2 type IIA (sPLA2-IIA), which has a
protective effect.
Methodology/Principal Findings: As glucocorticoids are well-known for their anti-inflammatory effects, our aim was to
understand their direct effects on oxysterol-induced responses in oligodendrocytes (sPLA2-IIA stimulation and apoptosis).
We demonstrate that the synthetic glucocorticoid dexamethasone (Dex) abolishes the stimulation of sPLA2-IIA by 25-
hydroxycholesterol (25-OH). This inhibition is mediated by the glucocorticoid receptor (GR), which decreases the expression
of the oxysterol receptor Pregnane X Receptor (PXR) and interferes with oxysterol signaling by recruiting a common limiting
coactivator PGC1a. Consistent with the finding that sPLA2-IIA can partially protect oligodendrocytes against oxysterol-
triggered apoptosis, we demonstrate here that the inhibition of sPLA2-IIA by Dex accelerates the apoptotic phenomenon,
leading to a shift towards necrosis. We have shown by atomic force microscopy and electron microscopy that 25-OH and
Dex alters oligodendrocyte shape and disorganizes the cytoplasm.
Conclusions/Significance: Our results provide a new understanding of the cross-talk between oxysterol and glucocorticoid
signaling pathways and their respective roles in apoptosis and oligodendrocyte functions.
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Introduction
Cholesterol is predominantly located in the brain, especially
in the myelin sheaths formed by oligodendrocytes [1], which
are the myelinating glial cells of the central nervous system. It
also exerts pleiotropic effects on brain functioning and
homeostasis and gives rise to several neuroactive compounds,
mainly side-chain cleavage-derived steroid hormones and
oxysterols. The latter are natural compounds originating from
the enzymatic oxidation of cholesterol. There are several
different oxysterols, in particular 24(S)-hydroxycholesterol
(24(S)-OH), 25-hydroxycholesterol (25-OH) and 27-hydroxy-
cholesterol (27-OH), which are respectively synthesized by
means of the cholesterol hydroxylase enzymes CYP46A1, 25-
hydroxylase and 27-hydroxylase [2]. Oxysterols have been
shown to be implicated in cholesterol turnover, inflammation
and in neurodegenerative diseases such as Alzheimer’s disease
(AD) [3,4] and multiple sclerosis (MS) [5,6]. Not only neurons,
but also glial cells are targets for the actions of oxysterols:
they inhibit astrocyte proliferation after brain injury [7] and,
as we have previously shown, can cause oligodendrocyte
apoptosis [8].
Oxysterols (particularly 22(R)-OH, 24(S)-OH and 25-OH) bind
and activate the two isoforms of the nuclear receptor Liver X
Receptor (LXRa and LXRb) [9] and the Pregnane X Receptor
(PXR). However, not all oxysterols share the same mechanisms of
action; for example, 22(S)-OH does not activate LXR [10]. While
LXRb is ubiquitously expressed, LXRa is prominently expressed
in liver, kidney, intestine, adipose tissue, lungs and cerebellum.
Pregnane X Receptor (PXR), a xenobiotic-activated member of
the nuclear receptor superfamily, is expressed in brain, liver,
kidney and lung [11,12]. Both LXR and PXR receptors form
heterodimers with retinoic X receptor (RXR), the nuclear receptor
for 9-cis retinoic acid, and they regulate gene expression in the
nucleus by interacting with specific responsive elements. After
oxysterol binding, LXR-RXR or PXR-RXR dimers detach from
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PGC-1a (peroxysome proliferator activator receptor c coactivator-
1a) [14] and activate target gene expression.
Glucocorticoids are very well known for their anti-inflammatory
effects and are used in the treatment of inflammatory neurode-
generative diseases such as MS. Their anti-inflammatory effects
are mostly due to the ability of the glucocorticoid receptor (GR) to
repress pro-inflammatory gene expression by inhibiting inflam-
matory transcription factors such as NF-kB (Nuclear Factor k B)
or AP-1 (Activator Protein 1). Besides its direct interactions with
these nuclear transcription factors, the hormone-bound GR can
bind as a homodimer to glucocorticoid response elements (GRE)
that are present in the vicinity of glucocorticoid-modulated gene
promoters. Like the LXRs, the GR enhances transcription activity
by recruiting transcription coactivators such as p160s or PGC-1a.
We have previously shown that the secreted type IIA
phospholipase A2 (sPLA2-IIA) is stimulated by oxysterols in the
oligodendrocyte cell line 158N, suggesting a tight involvement of
myelinating glial cells in inflammatory processes [8]. Indeed,
sPLA2 is implicated in various inflammatory diseases such as
atherosclerosis and endotoxic shock [15]. In the CNS, sPLA2-IIA
is involved in inflammation [16] and can induce neuronal cell
death [17]. In AD, for example, sPLA2-IIA is up-regulated [18].
However, sPLA2 activity is not restricted to apoptosis, as it also
exerts beneficial actions: it has proliferative effects towards smooth
muscle cells [19,20,], uterine cells [21], monocytes [22] and it can
also exert neurotrophic effects, as has been demonstrated for
cerebellar granule neurons [23]. In oligodendrocytes, we have
demonstrated a protective role of sPLA2-IIA against oxysterol-
triggered apoptosis [8].
Remarkably, as we have previously demonstrated, oxysterols can
exert dual actions in oligodendrocytes [8]. On the one hand, they
can indeed induce the apoptosis of oligodendrocytes, but on the
other hand, they also stimulate the inflammatory sPLA2-IIA, which
partially protects oligodendrocytes from 25-OH-triggered cell
death. The aim of this work was to examine the influence of
glucocorticoids on oxysterol effects in oligodendrocytes. We
demonstrate that the stimulation of sPLA2-IIA by oxysterols can
be blocked by glucocorticoids. This inhibitory effect involves cross-
talks between glucocorticoid and oxysterol signaling, and in
particular between Pregnane X Receptor (PXR) and a common
coactivator, PGC-1a. As a consequence of their inhibitory influence
on sPLA2-IIA, glucocorticoids exacerbate the apoptotic effects of
oxysterols on oligodendrocytes, resulting in secondary necrosis.
Results
The Glucocorticoid Receptor Inhibits the Stimulation of
sPLA2-IIA by Oxysterols
We have previously shown that sPLA2-IIA is stimulated by
oxysterols in an oligodendrocyte cell line. As glucocorticoids have
anti-inflammatory actions, we examined whether they interfere
with the regulation of sPLA2-IIA by oxysterols. First, we assayed
the effects of Dex on sPLA2-IIA promoter activity. Oligodendro-
cytes were transiently transfected with a sPLA2-IIA promoter
driving the expression luciferase reporter gene (sPLA2-IIA-Luc)
and treated with 25-OH and/or Dex. While 25-OH (10 mM, 24 h)
doubled the promoter activity (p,0.001), Dex treatment (1 mM,
24 h) inhibited by 30% the basal promoter activity (p,0.05) and
blocked the stimulation by 25-OH (p,0.001) (figure 1A). The 25-
OH amount that we have used in cell culture is comparable to that
observed in the brain. As a matter of fact, we have previously
shown that oxysterol levels are high in rat brain: 24S and 25-OH
concentrations were about 25 mM and 0.16 mM, respectively [8].
Whether or not the GR was involved in this inhibition was
assessed using a siRNA targeting the GR (siGR). Real-time PCR
experiments showed that the siGR was able to knock-down GR
expression (Fig. 1B). When we transfected the siRNA against the
GR into these cells, the basal activity of the sPLA2-IIA promoter
was enhanced as well as the stimulation by 25-OH, while the
inhibitory effect of Dex was abolished. As expected, a mutated
siRNA directed against the GR had no effect on the regulation of
the sPLA2-IIA promoter (not shown). Conversely, overexpression
of the GR inhibited the basal activity of the sPLA2-IIA promoter
(not shown). These results show that the GR blocks the effect of
oxysterols at the level of the PLA2-IIA promoter, suggesting an
interference with oxysterol receptor signaling.
Glucocorticoid Inhibition of PXR Expression
In order to understand the molecular mechanism of the cross-
talk between GR and oxysterol receptors (LXR or PXR), we first
investigated whether Dex can modify the expression of LXRb and
PXR receptors, previously shown to be involved in the regulation
of sPLA2-IIA by oxysterols [8]. We therefore incubated the
oligodendrocyte cell line 158N with Dex (1 mM) during 24 hours
and analyzed by real time PCR the expression of LXRb and PXR.
As depicted in Figure 2, Dex did not alter the expression of LXRb,
but inhibited PXR transcript by 75%.
According to our previous results, PXR is only involved in the
stimulatory effects of mM concentrations of oxysterols, thus, the
selective reduction of PXR expression by Dex should only have an
inhibitory influence on the stimulation of sPLA2-IIA by elevated
levels of oxysterols. However, Dex also inhibits basal sPLA2-IIA
promoter activity. This prompted us to search for additional
mechanisms, such as competition for a common coactivator.
Cofactor PGC-1a Is Involved in LXR and PXR Regulation
of sPLA2-IIa Promoter
Another possible explanation for the inhibitory effect of the GR
on sPLA2-IIA promoter activity is the competition with PXR
(mediating the stimulation by micromolar concentrations of
oxysterols) or LXRb (involved in the regulation of basal promoter
activity) for the recruitment of a common coactivator. We
therefore intended to identify the coactivator implicated in the
stimulation of sPLA2-IIA by 25-OH. To activate transcription,
PXR and LXR need to recruit coactivators such as members of
the p160 family (SRC-1, SRC-2/GRIP1/TIF2 and SRC-3/p/
CIP/ACTR). Although the three p160 family members are
expressed in oligodendrocytes, their overexpression or their knock-
down by siRNA [24,25] did not alter oxysterol stimulation of
sPLA2 promoter (not shown). This observation ruled out the
implication of the p160s in the stimulation of the sPLA2-IIA
promoter by 25-OH in oligodendrocytes. We then tested whether
PGC-1a, a common coactivator for LXR and PXR, could be
involved in this pathway. RT-PCR showed that PGC-1a is indeed
expressed in the oligodendrocyte cell line (Fig. 3A). First, we
verified that PGC-1a is implicated in GR signaling in 158N cells.
Overexpressing PGC-1a dose-dependently enhanced Dex-medi-
ated transactivation of the glucocorticoid-sensitive promoter
(GRE)2-TATA (5-fold enhancement of promoter activity when
0.2 mg of PGC-1a was transfected) (Fig. 3B).
We subsequently addressed the question of the implication of
PGC-1a in the regulation of sPLA2-IIA promoter by 25-OH.
Overexpression of PGC-1a did not further enhance the stimula-
tory effects of 25-OH (Fig. 4A). But interestingly, the knock-down
of PGC-1a by siRNA significantly affected by 50% the basal
activity (p,0.05) and the oxysterol-induced stimulation (p,0.05)
of the sPLA2-IIA promoter (Fig. 4A). The efficacy of the siRNA
Steroid Effects in Glial Cells
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(not shown).
The competition for a common coactivator, PGC-1a, which is
present at limiting amounts in the cells, could be part of the cross-
talk between GR and LXR/PXR. To test this hypothesis, we
transfected 158N cells with the sPLA2-IIA promoter and
overexpressed PGC-1a. Then, the cells were treated with 25-
OH in the presence or absence of Dex. As expected, Dex
repressed the effects of 25-OH at the level of the sPLA2-IIA
promoter. Interestingly, when we enhanced the intracellular
amounts of PGC-1a, Dex was not able to repress 25-OH effects
any more (Fig. 5).
Cross-Talk between 25-OH Oxysterols and
Dexamethasone on Apoptosis
We have formerly described that sPLA2-IIA partially protects
oligodendrocytes from 25-OH-triggered apoptosis. As a matter of
fact, incubation of the oligodendrocyte 158N cell line with a
conditioned medium enriched with sPLA2-IIA to some extent
protected from the deleterious effects of 25-OH. Since Dex
inhibits sPLA2-IIA, it could be expected to exacerbate the
apoptotic effects of oxysterol. We thus studied the combined
effects of Dex and 25-OH on oligodendrocyte apoptosis.
Figure 1. Effect of Dex and implication of the GR in sPLA2-IIA promoter activity. A/ 158N cells were transiently transfected with 0.2 mgo f
sPLA2-IIA(1 kb) and 0,1 mg of pRSV-bGal plasmids in the presence of 0.2 mg of mock vector (NT) or siRNA directed against the GR (siGR). Eighteen
hours after transfection, cells were incubated with 25-OH (10
25 M) and/or Dex (10
26 M) for 24 h, and then luciferase and b-galactosidase activities
were analyzed. Results are expressed as percentage of the basal activity; they represent the mean +/2 SEM of 10 independent experiments
performed in duplicate. In all experiments *p,0.05, **p,0.01, ***p,0.001 by using Bonferroni’s test after ANOVA. B/ Test of the efficacy of the siRNA:
Total RNA from 158N cells transfected with either non targeting siRNA or siRNA against GR was prepared. Real time RT-PCR was performed. 26S RNA
was detected by specific primers and used to normalize GR expression levels.
doi:10.1371/journal.pone.0008080.g001
Figure 2. Effect of dexamethasone on the expression of LXRb
and PXR. 158N cells were incubated with Dex (1 mM) during 24 h.
Total RNA was extracted and real-time PCR experiments were
performed using primers recognizing specifically LXRb or PXR. Results
are expressed as the ratio of LXR or PXR expression over 26S. 100% is
the level in control cells. They represent the mean +/2 SEM of three
independent experiments. *p,0.05 when compared to control by using
Student’s t test.
doi:10.1371/journal.pone.0008080.g002
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48 h with or without co-treatment with Dex. Afterwards, we
analyzed by flow cytometry several phenomena occurring during
apoptosis: mitochondrial membrane potential (early apoptotic
event), caspase 3 activity (late event), Annexin V staining (in order
to detect phosphatidyl serine exposure in apoptotic cells) and
propidium iodide staining (a DNA intercalating agent). As
expected, the number of cells with low mitochondrial membrane
potential dramatically increased after 24 h and 48 h of 25-OH
treatment (59.7% at 24 h, 87.9% at 48 h vs 7.8% in the control
conditions) (Fig. 6A). The drop of mitochondrial membrane
potential appears to be associated with caspase-3 activation
(Fig. 6A). Annexin V and propidium iodide staining, which
respectively indicate apoptosis (% of cells with A
+PI
2) or necrosis
(% of cells with A
+PI
+), correlated with the previous observation:
3.8% of 158N cells were in apoptosis in control conditions, while
14.2% and 57.7% underwent apoptosis after 24 h and 48 h of 25-
OH treatment, respectively (Fig. 6B). Interestingly, a time-
dependent effect of 25-OH was not observed on the number of
cells undergoing necrosis (A
+/PI
+ cells).
Dexamethasone alone did not affect mitochondrial membrane
potential, caspase 3 activity (not shown), but slightly enhanced the
number of necrotic cells (Fig. 6C). A combined treatment with Dex
and 25-OH was able to partially rescue from the increase in the
number of cells with low mitochondrial membrane potential after
24 h of treatment (59.7% in 25-OH vs 40% in 25-OH + Dex
conditions) but did not modify the caspase-3 activation (Fig. 6A).
After 48 h, Dex+25-OH cotreatment did not reverse the increase
in the mitochondrial membrane potential nor caspase-3 activity
(Fig. 6A).
The time-dependent apoptotic effect of 25-OH was hammered
by Dex treatment (Fig. 6B–6C). Nevertheless, the total number of
dead cells was not affected by the combination of Dex+25-OH (vs
25-OH alone). To understand this discrepancy, we have analyzed
by flow cytometry the percentage of necrotic cells (Percentage of
PI
+/A
+ cells; Fig. 6B). We noticed that treatment of 158N cells
with 25-OH and Dex elicited an increase in cell necrosis, which
probably corresponds to a so-called ‘‘secondary necrosis’’.
Alteration of Oligodendrocyte Morphology and
Cytoplasm by 25-Hydroxycholesterol and
Dexamethasone
Our previous data [8] showed that 25-OH alters oligodendro-
cytes morphology. The effects of 25-OH and Dex on the shape of
oligodendrocytes were monitored by atomic force microscopy
(AFM), a technique that provides topographic images as well as
morphological parameters (height, surface, volume) of individual
attached living cells [26,27]. Figure 7 shows typical deflection
Figure 3. Implication of PGC-1a in GR transactivation. A/
Expression of PGC-1a. Total RNA was prepared from 158N cells. RT-
PCR experiments were performed using primers recognizing specifically
PGC-1a. PCR products were analyzed on agarose gel (2%) and visualized
under UV. 18S RNA was detected by specific primers and used to
normalize PGC-1a expression levels. B/ Implication of PGC-1a in the
glucocorticoid pathway. 158N cells were transiently cotransfected with
either 0.2 mg of (GRE)2-TATA-Luc, 0.1 mg of pRSV-bGal plasmids and
increasing amounts of PGC-1a expression vector, as indicated. Eighteen
hours after transfection, cells were incubated with Dex (10
26 M) for
24 h, and then luciferase and b-galactosidase activities were analyzed.
Results are expressed as percentage of the basal activity and represent
the mean +/2 SEM of at least four independent experiments performed
in duplicate. **p,0.01 when compared between cells transfected with
PGC-1a using Bonferroni’s test after ANOVA.
doi:10.1371/journal.pone.0008080.g003
Figure 4. Implication of PGC-1a in sPLA2-IIA promoter activity.
A/ Implication of PGC-1a in sPLA2-IIA promoter activity. 158N cells were
transiently transfected with either 0.2 mg of sPLA2-IIA(1 kb), 0.1 mgo f
pRSV-bGal plasmids with PGC-1a expression vector, with mock vector
or with a siRNA specifically directed against PGC-1a, as indicated.
Eighteen hours after transfection, cells were incubated with 25-OH
(10
25 M) for 24 h, and then luciferase and b-galactosidase activities
were analyzed. Results are expressed as percentage of the basal activity
and they represent the mean +/2 SEM of at least four independent
experiments performed in duplicate. *p,0.05 when compared between
control cells and cells transfected with PGC-1a expression vector or
siRNA against PGC-1a using Bonferroni’s test after ANOVA. B/ The
efficacy of the siRNA was analyzed by RT-PCR. 158N cells were
transiently transfected with a siRNA specifically directed against PGC-
1a. 24 hours after transfection, total RNA was prepared. RT-PCR
experiments were performed using primers recognizing specifically
PGC-1a. PCR products were analyzed on agarose gel (2%) and visualized
under UV. 18S RNA was detected by specific primers and used to
normalize PGC-1a expression levels.
doi:10.1371/journal.pone.0008080.g004
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the absence or presence of 25-OH (10
25 M) and/or Dex (10
26 M)
during 24 h. Cytoskeleton elements are clearly visible underneath
the plasma membrane of control cells. The exposure of 158N cells
to 10 mM 25-OH during 24 h resulted in striking alterations of cell
morphology and important variations both in height and width
(figure 7B). As depicted in Figure 7C, treatment with 25-OH
elicited a significant increase of the cell maximum height from
2.1160.21 mm to 3.9860.40 mm, an edge retracted by approx-
imately 10 mm and a spherical shape enhancement. The surface of
the 25-OH-treated cells was reduced by 59% compared to the
control, whereas the total volume was diminished by 32%.
There was no significant effect of Dex alone on the morphology
or on the cell surface and the shape of oligodendrocyte cell line.
These morphometric alterations elicited by 25-OH were reversed
by co-treatment with Dex (Figure 7A). Figure 7C shows that with a
combined treatment with 25-OH and Dex, the cell surface and
volume were brought back to comparable values as control
condition. Dex+25-OH treatment provoked a decrease in
oligodendrocyte height comparing to 25-OH condition. Never-
theless, after incubation with Dex+25-OH, the ratio cell volume/
surface increased as in the case of treatment with 25-OH,
indicating a slight swelling of the cell. Besides, cytoskeleton
elements were not visible any more underneath the plasma
membrane of the cells. These morphometric data show that 25-
OH and Dex provoke profound, but different, modifications in
oligodendrocyte cell line shape. We tried to image by AFM the
oligodendrocytes after 48 h of incubation with 25-OH and/or
Dex. However, we were not able to have accurate images of the
cells at this time point because the cells are in a very bad condition
due to the increase of the number of dead cells or cells undergoing
apoptosis/necrosis. At 48 h, the cells detached rapidly when the
AFM tip touches the ‘living’ remaining cells. As we have precoated
the dishes for AFM experiments, we have verified that this coating
did not alter neither the apoptotic/necrotic signal nor the sPLA2-
IIA regulation by Dex and/or 25-OH (not shown).
To further analyze the effects of 25-OH and Dex on
oligodendrocytes, we performed electron microscopy of oligoden-
drocytes incubated with 25-OH and/or Dex. In control
conditions, mitochondria have a typical conformation with normal
cristae membranes within an unaffected cytoplasm (Figure 8A).
The addition of 25-OH modifies the cytoplasm, which becomes
clearer with a slight swelling of both the Golgi apparatus and the
endoplasmic reticulum (ER). The mitochondria are also affected:
they become electron dense and exhibit some intramitochondrial
lumen. The treatment with Dex seems to affect firstly the
mitochondria that appear translucide and lose their typical
conformation (cristae membrane disappearance). The combined
treatment with 25-OH and Dex induces a dramatic swelling of the
Golgi apparatus, associated to a minor extent with ER swelling.
The cytoplasm is also disorganized. Curiously, some mitochondria
seem to preserve their conformations whereas others look as if they
have been subjected to microautophagy (elimination of unwanted
ROS-producing mitochondria).
We have performed TEM after 48 h of treatment with Dex
and/or 25-OH (Fig. 8B). Dex (48 h) treated cells have similar, but
more pronounced, stigmata than at 24 h: the mitochondria are
affected and the ER is dilated. With 25-OH there an important
presence of autophagosomes and the mitochondria are affected.
The treatment with 25-OH + Dex leads to the clear occurrence of
an important mitophagy, taking place in a totally disordered
cytoplasm with widely enlarged ER and lumen at the level of the
nuclear envelop.
Discussion
Oxysterols are important molecules for brain homeostasis, and
their levels are altered in several neurodegenerative disease like
AD and demyelinating diseases (MS, Smith-Lemli-Optiz disease)
[5,6,28]. Our previous data showed that oxysterols, and in
particular 25-OH, can provoke oligodendrocyte apoptosis, but
also stimulate the synthesis of the sPLA2-IIA with partial
protective effects [8]. In this study, we have analyzed the effects
of the glucocorticoid Dex (often used as anti-inflammatory agent)
on oxysterol-induced apoptosis and sPLA2-IIA induction. We
have demonstrated that Dex blocks sPLA2-IIA stimulation by
oxysterols, an effect which is mediated by the GR. As a matter of
fact, GR silencing causes an increase in sPLA2-IIA basal activity as
well as its induction by oxysterols. Moreover, it abolishes Dex
inhibitory effects towards sPLA2-IIA. Dex negative effects on 25-
OH are restricted to sPLA2-IIA because they did not affect the
expression of the cholesterol transporter (ABCA1), another 25-OH
target gene (not shown).
We have demonstrated two mechanisms of action that could
account for the cross-talk between GR and oxysterol receptors in
oligodendrocytes: (i) alteration by the GR of LXRb or PXR
expression; (ii) competition between LXR and GR for a common
coactivator. We have previously shown that oligodendrocytes are
able to produce oxysterols that act by an autocrine/paracrine loop
via LXRb and increase the basal activity of the sPLA2-IIA
promoter, while PXR is responsible for the stimulation of sPLA2-
IIA by higher amounts of added 24(S)-OH or 25-OH. PCR
experiments demonstrated that PXR expression, but not LXRb,
expression was affected by Dex, which is in accordance with
findings of Greger et al in liver [29]. We also explored the second
possibility, namely competition for a common coactivator between
Figure 5. PGC-1a implication in sPLA2-IIA promoter regulation.
158N cells were transiently transfected with 0.2 mg of sPLA2-IIA(1 kb),
0.1 mg of pRSV-bGal plasmids and with 0.1 mg of PGC-1a expression
vector or mock vector, as indicated. Eighteen hours after transfection,
cells were incubated with 25-OH (10
25 M) and/or Dex (10
26 M) for
24 h, and then luciferase and b-galactosidase activities were analyzed.
Results are expressed as percentage of the basal activity; they represent
the mean +/2 SEM of at least four independent experiments performed
in duplicate. **p,0.01, when comparing between 25-OH and Dex+25-
OH using Bonferroni’s test after ANOVA.
doi:10.1371/journal.pone.0008080.g005
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regulation of sPLA2-IIA promoter by 25OH, we focused our
attention on PGC-1a, another common coactivator. We have
shown that PGC-1a knock-down altered 25OH signaling at the
level of the sPLA2-IIA promoter. Furthermore, PGC-1a overex-
pression enhanced glucocorticoid signaling at the level of a
classical (GRE)2-TATA construct. Consequently, PGC-1a is
implicated in both signaling pathways in 158N cells. We
overexpressed PGC-1a in the oligodendrocyte cell line, and we
obtained a reduction in the repressive effect of Dex at the level of
sPLA2-IIA promoter. These results suggest that GR competes with
LXR/PXR for a common limiting coactivator, PGC-1a,a
versatile coactivator that interacts with numerous nuclear
receptors, including LXR, PXR and GR. This kind of competitive
mechanism has already been described between PXR and HNF-4,
which struggle for PGC-1a [30]. As Dex is also well known to be a
common ligand for PXR and GR, one could wonder if the cross-
talk between these receptors is due to the ability of Dex to bind to
both of them. Dex and 25-OH effects are opposite (25-OH
activates sPLA2-IIA promoter while Dex represses it). We have
shown by using siRNA against either GR or PXR that the
stimulation of sPLA2-IIA by 25-OH is PXR-dependent, while the
repression by Dex is GR dependent. A siRNA directed against
PXR did not relief from Dex inhibition (not shown) but a siRNA
targeting GR blocked Dex inhibitory effects. Thus, the cross-talk
between PXR and GR is not mediated by the binding of Dex to
both receptors.
There is increasing evidence in favor of the existence of a cross-
talk between oxysterol and glucocorticoid signaling pathways.
LXRs can strongly down-regulate the expression and activity of
11b-hydroxysteroid deshydrogenase type I (11b-HSD-1) [31],
which controls the concentration of active glucocorticoids by
converting inactive corticosteroids into biologically active ones.
Moreover, 24(S)-OH was shown to block the enzymatic activity of
Figure 6. Cross-talk between oxysterols and glucocorticoids in oligodendrocyte death. A/ Histograms showing cells treated with or
without 25-OH in presence or absence of dexamethasone. As described here, the mitochondrial membrane potential was determined by DiOC6(3)
and propidium iodide staining of the cells, followed by flow cytometry analysis. The different categories of cell populations as described in (A) have
been simultaneously plotted. In all cases, 10.000 cells have been counted. The standard deviations have been extracted from five different
experiments. B/ Biparametric flow cytometric analysis of oligodendrocytes treated with or without 25-OH in presence or absence of dexamethasone.
Apoptotic cells were identified as Annexin V-FITC positive/PI negatives, whereas necrotic cells or cells exhibiting secondary necrosis were considered
as Annexin V-FITC positive and PI positive. The addition of the two populations gives the total cell death in the present conditions. A typical
experiment with cells treated for 24 h or 48 h is presented. 10.000 cells have been counted for each representation (the cell debris and aggregated
cells have been excluded from the analysis by selection based on their light scattering properties). C/ Histograms of the cells treated with or without
25-OH in the presence or absence of dexamethasone. The different categories of cell populations as described in (B) have been simultaneously
plotted. In all cases 10.000 cells have been counted. The standard deviations have been extracted from five independent experiments.
doi:10.1371/journal.pone.0008080.g006
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metabolism. Hypercorticosteronemia has been described in LXR
deficient mice [32], and these mice overexpress several genes
implicated in steroid metabolism (StAR, CYP11A1 and 3b-HSD-
1). Furthermore, LXR agonist reduces GR expression [33],
whereas GR in turn can suppress LXR expression [34]. The
present study adds two novel mechanisms to the cross-talk between
glucocorticoids and oxysterols, namely, the inhibition of PXR
expression and the competition for PGC-1a.
What is the physiological impact of this cross-talk? We have
shown that 25-OH provokes oligodendrocyte apoptosis by an
LXR independent manner. At the same time, 25-OH activates
sPLA2-IIA by means of the LXR/PXR, with a partial protective
effect towards oligodendrocytes. Thus, we put forward that
activation of sPLA2-IIA may be able to counterbalance the
apoptotic effects of 25-OH. Since Dex can block the activation of
sPLA2-IIA by 25-OH, it can be expected to dampen oligoden-
drocyte defenses and to accelerate cell death. This hypothesis is
supported by the enhancement of the number of necrotic cells
after 48 h of treatment with Dex+25-OH, which is in favor of a
secondary necrosis that occurs after an acceleration of the
apoptotic process. A second line of evidence confirms this
observation. We have assayed the production of superoxide
anions, which are reactive oxygen species (ROS). While in control
cells the percentage of superoxide anion is about 15%+/23%, 25-
OH incubation augmented the amount of superoxide anion
(29%+/2 3% at 24 h and 23%+/24% at 48 h). Interestingly,
when oligodendrocytes were incubated with Dex and 25-OH, we
detected a larger amount of cells producing superoxide anion
(35%+/25% at 24 h and 57%+/27% at 48 h). The death of
oligodendrocyte under Dex+25-OH conditions takes place in a
context where the production of ROS is increased. This
observation could explain the shift from apoptotic (25-OH) to
necrotic (25-OH+Dex) death.
Furthermore, arguments obtained from atomic force microsco-
py as well as electron microscopy sustain this assumption. We have
demonstrated that 25-OH and Dex profoundly modify oligoden-
drocyte shape, cytoplasm and mitochondria. After incubation with
25OH, the shape of the oligodendrocytes became spherical,
suggesting the loss of focal adhesion sites that prepares the
detachment of the cells. This was accompanied by mitochondrial
defects and a slight swelling of both the Golgi apparatus and the
endoplasmic reticulum. The treatment with Dex did not modify
cell shape but affected the mitochondria. The combined treatment
with 25OH and Dex gave the impression of an improvement of
cell external morphology. Nevertheless, oligodendrocyte shape is
Figure 7. Alteration of oligodendrocytes morphology by 25-OH and Dex. A/ Representative AFM deflection images of living
oligodendrocytes in culture medium. 158N cells were cultured on a matrix of collagen I during 24 h and then cells were incubated or not with 25OH
(10
25 M) and/or Dex (10
26 M) during 24 h. The cells were then imaged with AFM in contact mode. This experiment was repeated three times, and
typical images are presented here. Image scan size: 60 mm660 mm. B/ Height profiles corresponding to the cross-sections of the same cells as in (A).
C/ Histogram of the morphometric parameters, i.e. maximum cell height, cell surface and total cell volume of 158N cells, incubated or not. All
averages are calculated from five cells.
doi:10.1371/journal.pone.0008080.g007
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morphological observations corroborate a switch to oligodendro-
cyte necrosis.
In conclusion, we have shown that Dex is able to accelerate the
death of oligodendrocytes by inhibiting sPLA2-IIA. Apoptosis was
initiated by 25-OH and sped up and shifted to secondary necrosis
by glucocorticoid in order to get rid of the non-functional
oligodendrocytes. These phenomena are orchestrated by nuclear
receptors (LXR, PXR and GR) that compete with a common
coactivator PGC1a on the level of sPLA2-IIA promoter.
Materials and Methods
Cell Culture
The immortalized mouse oligodendrocyte cell line 158N, which
has preserved oligodendrocyte characteristics and expresses myelin
proteins [35], was maintained in Dulbecco’s minimal essential
medium (DMEM) supplemented with 5% fetal calf serum (Gibco),
100 U/mL penicillin and 100 mL/mL streptomycin (Gibco).
Plasmids
The Luciferase construct containing the sPLA2-IIA promoter
has already been described [36]. The (GRE)2-TATA-luc plasmid
was described by Grenier et al. [24]. The siRNAs directed against
PGC-1a and GR as well as control siRNA (non targeting (NT)
siRNA) were purchased from Dharmacon (Lafayette, CO). PGC-
1a was graciously provided by Dr JF Louet (Houston, TX, USA).
Transient Transfections
158N cells were transiently transfected using Effecten reagent
(QIAGEN). One day before the transfection, 158N cells (1.5610
5
cells/well) were seeded into 6-well plates and incubated in DMEM
culture medium containing 5% fetal calf serum. The sPLA2-IIA-
luc plasmid (0.3 mg), the pRSV-bGalactosidase expression vector
(0.1 mg) and the coactivator expression vectors, mock vectors or
siRNAs at the concentrations indicated in the figure legends were
mixed with a solution containing Effecten reagents (0.85 mg/ml)
in serum-free DMEM, as suggested by the manufacturer. The
mixture was then added to the cells overnight. One day after the
transfection, the medium was replaced by DMEM containing 5%
charcoal-treated fetal calf serum containing or not 25-hydro-
xycholesterol or 24(S)-hydroxycholesterol (10 mM) and/or the GR
agonist dexamethasone (1 mM) during 24 hours.
Luciferase activity was determined using the enzymatic method
described in Massaad et al. [37]. The b-galactosidase activity was
used to normalize the transfection efficiency and measured as
described in Tallec et al [38].
Quantitative and Non Quantitative RT-PCR
Total RNA from cultured 158N cells was obtained using RNA
now (Ozyme, France) and 1 mg was reverse transcribed with
random primers from Biolabs (Beverly, MA) and Reverse
Transcriptase M-MuLV-RT from Finnzymes (Espoo, Finland).
PCR experiments were performed using Taq DNA polymerase
purchased from Biolabs (Beverly, MA) and primers specific for
each gene from Proligo (Boulder, CO). PCR products were
analyzed on agarose gel (2%) and visualized under UV.
Quantitative PCR was performed with standard protocols using
SYBRHGreen (ABgene, France) as fluorescent detection dye in
ABI PRISMH 7000 in a final volume of 25 ml which also contained
300 nM primers (Eurofins Genomics Operon, Orsay, France) and
20 ng of reverse transcribed RNA in 96-well plates. For the
characterization of the generated amplicons and to control the
contamination by unspecific by-products, a melting curve analysis
Figure 8. Alteration of oligodendrocytes cytoplasm by 25-OH
and Dex. Transmission electron micrographs of 158N cells incubated
or not with 25OH (10
25 M) and/or Dex (10
26 M) during 24 h (A) or 48 h
(B). The cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate
buffer (pH 7.2) for 1 h at 4uC and TEM was performed. Insets:
magnification showing representative mitochondria. By comparison
with controls, mitochondria cristae seem to disappear. They partly lost
their normal structure (arrows). Scale bar=2 mm.
doi:10.1371/journal.pone.0008080.g008
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mean of at least three independent experiments was calculated. All
results were normalized to the 26S mRNA level and calculated
using the Delta Ct method. The primer sequences used in real
time PCR are listed below:
PGC-1a sense: CCTTGCCATTGTTAAGACC;
PGC-1a antisense: TGCTGCTGTTCCTGTTTTT;
GR sense: CAAAGGCGATACCAGGATTC;
GR antisense: TCAGGAGCAAAGCATAGCAG;
LXRb sense: CTTGGTGGTGTCTTCTTGA;
LXRb antisense: TGTGGTAGGCTGAGGTGTA;
PXR sense: CAAGGCCAATGGCTACCA;
PXR antisense: CGGGTGATCTCGCAGGTT;
26S sens: AGGAGAAACAACGGTCGTGCCAAAA;
26S antisens: GCGCAAGCAGGTCTGAATCGTG.
18S sense: CTCGGGCCTGCTTTGAACAC;
18S antisense:CTACCACATCCAAGGAAGGC
Study of Apoptosis by Flow Cytometry
Changes in mitochondrial membrane potential difference
(DYm) were evaluated by incubating cells (Oligodendrocytes,
5610
5/ml) for 15 min at 37uC, with DiOC6(3) (stock solution
1 mM in ethanol, final concentration 10 nM). Cells were then
analysed by using the FACS calibur cytometer. The fluorescence
was collected after suitable compensation, in FL-1 (530630 nm)
channel for DiOC6(3) together with the PI permeability assay
recorded in FL3 (PL; long pass.670 nm).
Late apoptotic events and/or secondary necrosis were
estimated through the estimation of the exposed phosphatidyl-
serine (PS) on the outer plasma membrane leaflet by staining
cells with annexin V-FITC (1 mg/ml) for 10 min at 4uC. The
annexin V-FITC absorption on cell surface was monitored by
flow cytometry in FL-1 channel (530630 nm), together with the
membrane integrity assay using propidium iodide (PI, 1 mg/ml),
which emitted in FL-3 channel (long pass.670 nm), as
classically described.
Caspase-3-like activity was assayed by flow cytometry in intact
cells incubated with the cell-permeable fluorogenic caspase
substrate PhiPhilux G1D2 (OncoImmunin Inc., Kensington,
MD, USA), which contains the GDEVDG sequence. Briefly,
oligodendrocytes cells were harvested and washed twice in PBS
buffer. Cells were resuspended in 50 ml of PhiPhilux-containing
solution and incubated for 1 h at 37uC in the dark. Then, they
were washed and suspended in PBS buffer. Fluorescence was
detected in FL-1 channel together with the membrane integrity
assay using PI (1 mg/ml) as described above.
Superoxide anion production was assayed on treated cells
incubated with 2.5 mM dihydroethidium for 15 min at 37uC for,
and then washed and resuspended in phosphate-buffered saline
pH 7.2. They were counterstained with 2 mM TOPRO-3 (1 mg/
ml stock solution) to monitor cell viability just before flow
cytometry analysis. The fluorescence was collected after excitation
at 488 nm in the FL-2 channel (585642 nm) for HE and after
exciation at 635 nm in the FL-4 channel (661616 nm) channel for
TOPRO-3.
Atomic Force Microscopy
AFM measurements were performed on a commercial AFM
Bioscope (Nanoscope IIIa, Digital Instruments, Veeco, USA) in
contact mode. Using a fluid cell, AFM contact mode images of
living cells were recorded in culture medium using a long V-shape
silicon nitride cantilever (320 mm in length), with a nominal spring
constant of 0.01 mN/m (MLCT-AU microlevers, Veeco, France)to
minimize the force applied to the cells. The image fields
(60 mm660 mm) were obtained at 0.5 Hz; 6 to 10 min were
required to scan the entire sample. 158N cells cultured on collagen I
(rat tail, BD Biosciences, France) coated Petri dishes were mounted
directly on the stage of the inverted microscope (Olympus IX 70,
France) of the Bioscope to choose viable cells at relative low density.
The samples were equilibrated in the cell medium for a 10 to 15-
minute period to avoid problem with drift of the equipment.
Morphometric parameters (maximum height, cell surface and
cell volume) were determined from the AFM topography images
using the Nanoscope software (v5.12). First, the individual image
was plane-fitted and then the total surface and volume of the cell
were analyzed using the bearing software feature. Individual cell
volume was based on the following principle: each pixel included
information on three dimensions. The x and y parameters are
given by the size of the scan area (50 mmo r6 0mm in our case) and
by the number of scan lines per image (512 here). The z (height)
information is given by the specific color level of each pixel. Thus,
after selection of the ‘‘base area’’ of the cell by a threshold
procedure, the total volume of the cell was simply obtained by
integrating the height over the base area.
Transmission Electron Microscopy
Cells were fixed with 2.5% glutaraldehyde in 0.1 M cacodylate
buffer (pH 7.2) for 1 h at 4uC, followed by 1% OsO4 for 1 h at
4uC. Subsequently, cells were contrasted in 1% Uranyl acetate,
dehydrated through a graded series of acetonitrile and embedded
in epoxy resin. Thin sections (100 nm) were cut on a Reichert
Ultracut E ultramicrotome, placed on 100-mesh copper grids,
contrasted in uranyl acetate and lead citrate and viewed under a
Hitachi H600 electron microscope (Tokyo, Japan).
Statistical Analysis
Unless otherwise specified, means of treatment groups were
compared by one-way analysis of variance (ANOVA). When the
ANOVA showed that there were significant differences between
the groups, Bonferroni’s test was used for between-group compar-
isons.Student’sttest wasused forthe statisticalcomparisonbetween
two groups. A p value #0.05 was considered to be statistically
significant.
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